Literature DB >> 29733805

IL-17A, MCP-1, CCR-2, and ABCA1 polymorphisms in children with non-alcoholic fatty liver disease.

Ulas Emre Akbulut1, Hamdi Cihan Emeksiz2, Senol Citli3, Alper Han Cebi4, Hatice Ayca Ata Korkmaz5, Gaye Baki5.   

Abstract

OBJECTIVE: The prevalence of non-alcoholic fatty liver disease in children has risen significantly, owing to the worldwide childhood obesity epidemic in the last two decades. Non-alcoholic fatty liver disease is closely linked to sedentary lifestyle, increased body mass index, and visceral adiposity. In addition, individual genetic variations also have a role in the development and progression of non-alcoholic fatty liver disease. The aim of this study was to investigate the gene polymorphisms of MCP-1 (-2518 A/G) (rs1024611), CCR-2 (190 G/A) (rs1799864), ABCA1 (883 G/A) (rs4149313), and IL-17A (-197 G/A) (rs2275913) in obese Turkish children with non-alcoholic fatty liver disease.
METHODS: The study recruited 186 obese children aged 10-17 years, including 101 children with non-alcoholic fatty liver disease and 85 children without non-alcoholic fatty liver disease. Anthropometric measurements, insulin resistance, a liver panel, a lipid profile, liver ultrasound examination, and genotyping of the four variants were performed.
RESULTS: No difference was found between the groups in respect to age and gender, body mass index, waist/hip ratio, or body fat ratio. In addition to the elevated ALT levels, AST and GGT levels were found significantly higher in the non-alcoholic fatty liver disease group compared to the non non-alcoholic fatty liver disease group (p<0.05). The A-allele of IL-17A (-197 G/A) (rs2275913) was associated with non-alcoholic fatty liver disease (odds ratio [OR] 2.05, 95% confidence interval: 1.12-3.77, p=0.02).
CONCLUSIONS: The findings of this study suggest that there may be an association between IL-17A (-197 G/A) (rs2275913) polymorphism and non-alcoholic fatty liver disease development in obese Turkish children.
Copyright © 2018 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Children; Crianças; Doença hepática; Interleucina 17; Interleukin-17; Liver disease; Obesidade; Obesity; Polimorfismos de nucleotídeo único; Single-nucleotide polymorphisms

Mesh:

Substances:

Year:  2018        PMID: 29733805     DOI: 10.1016/j.jped.2018.03.005

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  3 in total

Review 1.  Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk.

Authors:  Siarhei A Dabravolski; Evgeny E Bezsonov; Mirza S Baig; Tatyana V Popkova; Ludmila V Nedosugova; Antonina V Starodubova; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

2.  Screening of co-pathogenic genes of non-alcoholic fatty liver disease and hepatocellular carcinoma.

Authors:  Ting Chen; Siwen Zhang; Dongmei Zhou; Peipei Lu; Xianglai Mo; Rashi Tamrakar; Xi Yang
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

Review 3.  Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative Review

Authors:  Fajar Dwi Astarini; Neneng Ratnasari; Widya Wasityastuti
Journal:  Iran Biomed J       Date:  2022-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.